Bryan A. Roecklein
Director/Board Member presso ADAMAS PHARMACEUTICALS, INC.
Profilo
Bryan A.
Roecklein is currently the Director at Adamas Pharmaceuticals LLC since 2021 and Vice President-Corporate Development at Supernus Pharmaceuticals, Inc. since 2015.
Previously, he worked as Director-Marketing & Commercial Development at MedPointe, Inc. from 2001 to 2011 and as Vice President-Business Development at Meda Pharmaceuticals, Inc. from 2001 to 2011.
He holds a doctorate degree from The University of Colorado and an undergraduate degree from the University of Maryland.
Posizioni attive di Bryan A. Roecklein
| Società | Posizione | Inizio |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2015 |
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 24/11/2021 |
Precedenti posizioni note di Bryan A. Roecklein
| Società | Posizione | Fine |
|---|---|---|
Meda Pharmaceuticals, Inc.
 Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | 01/01/2011 |
MedPointe, Inc.
 MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Sales & Marketing | 01/01/2011 |
Formazione di Bryan A. Roecklein
| The University of Colorado | Doctorate Degree |
| University of Maryland | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
MedPointe, Inc.
MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ. | Health Technology |
Meda Pharmaceuticals, Inc.
Meda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Meda Pharmaceuticals, Inc. manufactures and develops drugs and pharmaceuticals. The firm specializes in respiratory, allergy, central nervous system, and cough-cold products. Its products include Aerospan, Anadrol-50, Astelin, Astepro, BiferaRx, Butisol Sodium, Cesame, Colyte, Cortifoam, Demadex, Depen, Dipentum, Edlua, Rowasa, Optivar, Soma and Levsin. The company was founded in 2001 and is headquartered in Somerset, NJ. | Health Technology |
- Borsa valori
- Insiders
- Bryan A. Roecklein
